Section 5 of 9
Conclusion
Kerstin Piayda, Nabor Keweloh, Bernhard Unsöld, Samuel Sossalla, Amin Polzin, Fabian Voss, Jafer Haschemi, Marcel Giemsa, Ursula Marschall, Beata Hennig, Michael Beil, Malte Kelm, and Christian Jung · about 1 minutes
Age, frailty and comorbidities play an important role for survival prediction in patients undergoing M-TEER. Very old patients, patients with impairment of independence and abilities, and an increasing number of non-cardiac comorbidities significantly dimmish long-term survival in this real-world patient sample of >4.500 individuals undergoing M-TEER in the German health care system. M-TEER effectively reduces the number of heart failure hospitalizations, even though overall medical expenses and number of doctor-patient contacts in the ambulatory setting remain unchanged 12-months after the intervention.